AnaptysBio Stock Forum

$Travere Therapeutic(TVTX.US)$  Phase 3
$CG Oncology(CGON.US)$  Phase 3
$United Therapeutics(UTHR.US)$  Phase 3
$United Therapeutics(UTHR.US)$  Phase 3
$BioCardia(BCDA.US)$  Phase 3
$Insmed(INSM.US)$  Phase 3
$GlycoMimetics(GLYC.US)$  Phase 3
$Annexon(ANNX.US)$  Phase 3
$Lipocine(LPCN.US)$  Phase 3
$FibroGen(FGEN.US)$  Phase 3
$UroGen Pharma Ltd(URGN.US)$  Phase 3
$Lyra Therapeutics(LYRA.US)$  Phase 3
$Citius Pharmaceuticals(CTXR.US)$  Phase 3
$Jaguar Health(JAGX.US)$  Phas...

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies(ITCI.US)$  Phase 3
$CG Oncology(CGON.US)$  Phase 3
$Hutchmed (China)(HCM.US)$  Phase 3
$Viracta Therapeutics(VIRX.US)$  Phase 3
$GlycoMimetics(GLYC.US)$  Phase 3
$Annexon(ANNX.US)$  Phase 3
$Lipocine(LPCN.US)$  Phase 3
$FibroGen(FGEN.US)$  Phase 3
$UroGen Pharma Ltd(URGN.US)$  Phase 3
$Lyra Therapeutics(LYRA.US)$  Phase 3
$Citius Pharmaceuticals(CTXR.US)$  Phase 3
$Marinus Pharmaceuticals(MRNS.US)$  Phase 3
$BioCardia(BCDA.US)$  Phase 3...

$AnaptysBio(ANAB.US)$ Anaptys Announces Positive Top-Line Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP) HALT off at 8:30 AM est

Upgrades
• $Box Inc(BOX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $CF Industries Holdings(CF.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $135 (from $110)
• $New Gold(NGD.US)$: RBC Capital Upgrades to Outperform from Sector Perform - PT $1.25 (from $1)
• $Sensei Biotherapeutics(SNSE.US)$: Oppenheimer Upgrades to Outperform from Perform - PT $5
• $Senetas Corp Ltd(SEN.AU)$ : Tru...

Gapping up
In reaction to earnings/guidance:
• $Nutanix(NTNX.US)$ +15.4%,$Pure Storage(PSTG.US)$ +6.8%,$Credo Technology(CRDO.US)$ +5.9%,$Signet Jewelers(SIG.US)$ +3.6%,$SentinelOne(S.US)$ +3.4%,$Five Below(FIVE.US)$ +3.2%,$GMS Inc(GMS.US)$ +1.7%,$The Scotts Miracle(SMG.US)$ +0.9% (also CFO steps down, lowers FY22 FCF guidance, reaffirms all other guidance)
Other news:
• $Turquoise Hill Resources(TRQ.US)$ +12.3% (to be acquired by Rio T...

Gainers：
• $Gol Intelligent Airlines(GOL.US)$ +18.5% (earnings report)
• $LendingClub(LC.US)$ +16.9% (earnings report)
• $MaxLinear(MXL.US)$ +15.9% (earnings report)
• $Meta Platforms(FB.US)$ +15.8% (Facebook revenue slows but user gains boost stock)
• $Noodles & Co(NDLS.US)$ +15.2% (earnings report)
• $Avnet(AVT.US)$ +11.2% (earnings report)
• $Qualcomm(QCOM.US)$ +6.8% (Qualcomm reports earnings as smartphone market weakens)
• $Vale SA(VALE.US)$ +5.3% (an...

Upgrades
• $Cronos Group(CRON.US)$ : Barclays Upgrades to Equal Weight from Underweight - PT $5 (from $5.50)
• $Ecolab(ECL.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $196 (from $210)
• $Helios Technologies(HLIO.US)$ : Stifel Upgrades to Buy From Hold - PT $95 (from $85)
• $Manhattan Associates(MANH.US)$ : Raymond James Upgrades to Outperform From Market Perform - PT $170
• $Altria(MO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $57
• $Procter & Gamble(PG.US)$ : Truist ...